BAY 86-7548: (68)Ga-bombesin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 72722205 |
| MeSH ID | M0586632 |
| Synonym |
|---|
| npi2h5m36d , |
| 68ga-rm2 |
| unii-npi2h5m36d |
| 1444870-03-4 |
| bay 86-7548 |
| rm-2 ga-68 |
| bombesin (68ga) |
| (68ga)-rm2 |
| (68ga)dota-4-amino-1-carboxymethylpiperidine-d-phe-gln-trp-ala-val-gly-his-sta-leu-nh2 |
| gallium-68ga, (n-(2-(4-((2-(4,10-bis((carboxy-.kappa.o)methyl)-7-(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl-.kappa.n1,.kappa.n4,.kappa.n7,.kappa.n10)acetyl)amino)-1-piperidinyl)acetyl)-d-phenylalanyl-l-glutaminyl-l-tryptophyl-l-alanyl-l-valylglycyl- |
| bay-86-7548 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.11) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (25.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (12.50%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (62.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||